Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease
批准号:
10656558
负责人:
PAUL T KOTZBAUER
金额:
$71.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-08-01 至 2027-06-30
关键词:
AddressAffectAlzheimer&aposs disease related dementiaAmyloid beta-ProteinAttentionAutopsyBasal GangliaBasal Nucleus of MeynertBiological AssayBiological MarkersBrain regionCarrier ProteinsCell NucleusCognitionCognitiveConsentCorpus striatum structureDementiaDepositionDevelopmentEnzyme-Linked Immunosorbent AssayFreezingFunctional disorderGaitGoalsHigh Pressure Liquid ChromatographyImmunohistochemistryImpaired cognitionImpairmentIndividualLewy BodiesLewy Body DementiaLongitudinal StudiesLongitudinal cohortMeasuresMemoryMethodsNeocortexNerve DegenerationNeuronsNeurotransmittersOutcome MeasureParkinson DiseaseParkinson&aposs DementiaParticipantPathologicPathologyPatientsPatternPersonsPhenotypePresynaptic TerminalsProteinsSamplingSubstantia nigra structureThalamic structureTherapeutic TrialsTimeTissue SampleTissuesVisuospatialabeta accumulationalpha synucleinbrain tissuecholinergiccognitive functioncognitive impairment in Parkinson&apossdorsal raphe nucleusexecutive functionimprovedlocus ceruleus structuremisfolded proteinmotor symptomneocorticalnerve supplyneurobehavioralneuron lossnoradrenergicnovel strategiespostsynapticpresynapticprotein aggregationprotein biomarkerstau Proteinstau aggregationtherapeutic targettherapy development
中文摘要
摘要
帕金森病(PD)患者经常发生痴呆,这与新皮质
α-突触核蛋白(α-syn)沉积在路易体中,称为路易体痴呆(LBD),
阿尔茨海默病相关性痴呆(ADRD)。此外,神经元的损失和聚集的α-syn的沉积
也发生在多个皮质下核,包括黑质(多巴胺能)、Meynert基底核
(胆碱能)、蓝斑(去甲肾上腺素能)和中缝背核(肾上腺素能)。α-syn蓄积
可能导致皮质神经元的变性,这也可能受到广泛的Aβ的影响。
在大约55%的PD痴呆病例中发生的tau蛋白蓄积和广泛的tau蛋白蓄积
在更少的情况下。然而,受影响的皮质下核团向丘脑、纹状体、边缘系统和丘脑投射。
新皮层区域,以及这些核的神经支配的丧失也可能导致认知障碍,
警局我们开发了死后组织分析方法来量化α-syn、Aβ和
tau蛋白,以突触末端丢失为标志的神经元变性,以及神经元的神经支配投射的丢失。
多巴胺能、多巴胺能、去甲肾上腺素能和胆碱能皮质下神经元。在这个项目中,我们将收集
从PD参与者的纵向研究中进行尸检,该研究测量认知、神经行为功能和
步态我们将从冷冻的脑组织中提取小脑、基底神经节、边缘系统和新皮层区域的样本,
目的:1)确定α-syn、Aβ、β-淀粉样蛋白(α-syn)、β-淀粉样蛋白(β-淀粉样蛋白)、β-淀粉样蛋白(β-淀粉样蛋白)、β-淀粉样蛋白(β-淀粉样蛋白)、β-淀粉样蛋白(β-淀粉样蛋白)之间的关系
以及tau积累、神经元变性和皮质下投射的丧失。2)确定是否
病理性蛋白质积累、神经元变性和皮质下核投射的丧失与
整体认知和特定认知表型,包括注意力、记忆力、视觉空间和
执行功能明确PD认知功能障碍的病理学基础,将为进一步研究PD认知功能障碍提供新的思路。
为PD治疗试验的治疗靶点、生物标志物和结局指标提供指导。
英文摘要
Abstract
People with Parkinson disease (PD) frequently develop dementia, which is associated with neocortical
deposition of alpha-synuclein (α-syn) in Lewy bodies and referred to as Lewy body dementia (LBD), an
Alzheimer’s Disease Related Dementia (ADRD). In addition, neuronal loss and deposition of aggregated α-syn
also occurs in multiple subcortical nuclei including substantia nigra (dopaminergic), nucleus basalis of Meynert
(cholinergic), locus coeruleus (noradrenergic) and dorsal raphe nuclei (serotonergic). Accumulation of α-syn
likely contributes to degeneration of cortical neurons, which may also be affected by widespread Aβ
accumulation that occurs in approximately 55% of PD with dementia cases and widespread tau accumulation
in fewer cases. However, the affected subcortical nuclei project rostrally to thalamic, striatal, limbic and
neocortical regions, and the loss of innervation from these nuclei also may contribute to cognitive impairment in
PD. We developed postmortem tissue analysis methods to quantify pathologic accumulation of α-syn, Aβ and
tau, neuronal degeneration marked by loss of synaptic terminals, and loss of innervating projections from
dopaminergic, serotonergic, noradrenergic and cholinergic subcortical neurons. In this project we will collect
autopsies from a longitudinal study of PD participants that measures cognition, neurobehavioral function and
gait. We will sample cerebellar, basal ganglia, limbic and neocortical regions from frozen brain tissue for each
autopsy case and analyze the tissue with the following goals: 1) Determine the relationship between α-syn, Aβ
and tau accumulation, neuronal degeneration, and loss of subcortical projections. 2) Determine whether
pathologic protein accumulation, neuronal degeneration and loss of projections from subcortical nuclei relate to
global cognition and specific cognitive phenotypes, including impaired attention, memory, visuospatial and
executive function. Defining the pathologic substrates for cognitive impairment in PD will provide further
guidance for therapeutic targets, biomarkers, and outcome measures for therapeutic trials in PD.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Imaging Ligands for Alpha-Synuclein Fibril Accumulation in Multiple System Atrophy
-
批准号:10452228
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2022
-
负责人:PAUL T KOTZBAUER
-
依托单位:
Imaging Ligands for Alpha-Synuclein Fibril Accumulation in Multiple System Atrophy
-
批准号:10581664
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2022
-
负责人:PAUL T KOTZBAUER
-
依托单位:
NAPS2 Biofluid Core
-
批准号:10457859
-
项目类别:
-
资助金额:$48.95万
-
财政年份:2021
-
负责人:PAUL T KOTZBAUER
-
依托单位:
NAPS2 Biofluid Core
-
批准号:10674046
-
项目类别:
-
资助金额:$48.48万
-
财政年份:2021
-
负责人:PAUL T KOTZBAUER
-
依托单位:
NAPS2 Biofluid Core
-
批准号:10187085
-
项目类别:
-
资助金额:$47.73万
-
财政年份:2021
-
负责人:PAUL T KOTZBAUER
-
依托单位:
IDENTIFICATION OF FLUORESCENT LIGANDS FOR ALPHA SYNUCLEIN FIBRILS
-
批准号:9789973
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2018
-
负责人:PAUL T KOTZBAUER
-
依托单位:
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA
-
批准号:10246509
-
项目类别:
-
资助金额:$80.57万
-
财政年份:2018
-
负责人:PAUL T KOTZBAUER
-
依托单位:
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA
-
批准号:10473717
-
项目类别:
-
资助金额:$80.57万
-
财政年份:2018
-
负责人:PAUL T KOTZBAUER
-
依托单位:
Structural Biology of Alpha-Synuclein in Lewy Body Dementia
-
批准号:10729722
-
项目类别:
-
资助金额:$423.15万
-
财政年份:2018
-
负责人:PAUL T KOTZBAUER
-
依托单位:
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA
-
批准号:10023948
-
项目类别:
-
资助金额:$80.57万
-
财政年份:2018
-
负责人:PAUL T KOTZBAUER
-
依托单位:
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA
-
批准号:9791034
-
项目类别:
-
资助金额:$80.42万
-
财政年份:2018
-
负责人:PAUL T KOTZBAUER
-
依托单位:
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease
-
批准号:9321450
-
项目类别:
-
资助金额:$51.15万
-
财政年份:2016
-
负责人:PAUL T KOTZBAUER
-
依托单位:
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease
-
批准号:10522079
-
项目类别:
-
资助金额:$74.27万
-
财政年份:2016
-
负责人:PAUL T KOTZBAUER
-
依托单位:
THERAPEUTIC APPROACHES FOR NEURODEGENERATION CAUSED BY PLA2G6 MUTATIONS
-
批准号:8322590
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2011
-
负责人:PAUL T KOTZBAUER
-
依托单位:
THERAPEUTIC APPROACHES FOR NEURODEGENERATION CAUSED BY PLA2G6 MUTATIONS
-
批准号:8243020
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2011
-
负责人:PAUL T KOTZBAUER
-
依托单位:
Neurodegenerative consequences of PanK2 mutations
-
批准号:6809319
-
项目类别:
-
资助金额:$17.44万
-
财政年份:2004
-
负责人:PAUL T KOTZBAUER
-
依托单位:
Neurodegenerative consequences of PanK2 mutations
-
批准号:7216264
-
项目类别:
-
资助金额:$17.6万
-
财政年份:2004
-
负责人:PAUL T KOTZBAUER
-
依托单位:
Neurodegenerative consequences of PanK2 mutations
-
批准号:7081780
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2004
-
负责人:PAUL T KOTZBAUER
-
依托单位:
Neurodegenerative consequences of PanK2 mutations
-
批准号:7029740
-
项目类别:
-
资助金额:$17.6万
-
财政年份:2004
-
负责人:PAUL T KOTZBAUER
-
依托单位:
Neurodegenerative consequences of PanK2 mutations
-
批准号:7394998
-
项目类别:
-
资助金额:$17.6万
-
财政年份:2004
-
负责人:PAUL T KOTZBAUER
-
依托单位:
海外基金